We are live on
!
Find out more
WCM Investment Management Portfolio holdings
AUM
$43.8B
1-Year Est. Return
42.28%
This Fund
S&P 500
This Quarter
Est. Return
+13.17%
1 Year Est. Return
+42.28%
3 Year Est. Return
+149.38%
5 Year Est. Return
+174.91%
10 Year Est. Return
+944.06%
AUM
$18.6B
AUM Growth
+$1.94B
(+12%)
Cap. Flow
+$56M
Cap. Flow
% of AUM
0.3%
Top 10 Holdings %
Top 10 Hldgs %
70.09%
Holding
166
New
14
Increased
113
Reduced
26
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$702M |
| 2 |
ASML
ASML
|
+$137M |
| 3 |
Intercontinental Exchange
ICE
|
+$110M |
| 4 |
Church & Dwight Co
CHD
|
+$106M |
| 5 |
Smith & Nephew
SNN
|
+$73.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$1.21B |
| 2 |
Agilent Technologies
A
|
+$104M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$78.4M |
| 4 |
Boston Scientific
BSX
|
+$58M |
| 5 |
Steris
STE
|
+$52.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.28% |
| 2 | Healthcare | 23.99% |
| 3 | Financials | 16.5% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Discretionary | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Fate Therapeutics
FATE
$326M
| $1.58M | 0.01% |
+80,651
| New | +$1.28M |
|
|
XLRN
152
DELISTED
Acceleron Pharma
XLRN
| $1.57M | 0.01% |
29,531
+16,680
| +130% | +$761K |
|
153
Simulations Plus
SLP
$371M
| $1.26M | 0.01% |
43,373
-82
| -0.2% | -$2.78K |
|
154
Tradeweb Markets
TW
$21.6B
| $924K | 0.01% |
19,926
+241
| +1% | +$10.4K |
|
155
Workday
WDAY
$44.4B
| $576K | ﹤0.01% |
3,500
| – | – |
|
156
Sony
SONY
$138B
| $271K | ﹤0.01% |
19,890
| – | – |
|
157
CGI
GIB
$15.5B
| $223K | ﹤0.01% |
2,660
| – | – |
|
|
158
Agilent Technologies
A
$41.2B
| – | – |
-1,357,963
| Closed | -$104M |
|
159
Bruker
BRKR
$8.14B
| – | – |
-29,866
| Closed | -$1.31M |
|
160
Merit Medical Systems
MMSI
$5.32B
| – | – |
-20,736
| Closed | -$632K |
|
161
Nice
NICE
$5.97B
| – | – |
-1,671
| Closed | -$240K |
|
|
SCHW
162
Charles Schwab
SCHW
$187B
| – | – |
-1,875,212
| Closed | -$78.4M |
|
163
SLB Ltd
SLB
$75B
| – | – |
-1,364,160
| Closed | -$46.6M |
|
|
THR
164
DELISTED
Thermon Group Holdings
THR
| – | – |
-265,592
| Closed | -$6.1M |
|
165
Yelp
YELP
$1.41B
| – | – |
-22,121
| Closed | -$769K |
|
|
IPHI
166
DELISTED
INPHI CORPORATION
IPHI
| – | – |
-21,409
| Closed | -$1.31M |
|
Similar funds
LP
DB
WCM Investment Management's Q4 2019 Portfolio in Review
As of Q4 2019, WCM Investment Management held 166 positions worth $18.6B, up 12% from $16.7B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
WCM Investment Management's Q4 2019 filing shows 14 new, 113 increased, 26 reduced and 9 closed positions. Its largest new stake was lululemon athletica: 3,295,460 shares worth $763M. The largest sale was Chubb, an estimated $1.21B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- WCM Investment Management's largest Q4 2019 buy was lululemon athletica: 3,295,460 shares worth $763M.
- WCM Investment Management added most to ASML in Q4 2019, an estimated $137M increase.
- WCM Investment Management's biggest Q4 2019 reduction was Chubb, cutting an estimated $1.21B.
- WCM Investment Management fully exited Agilent Technologies in Q4 2019, selling an estimated $104M.
- WCM Investment Management's ten largest holdings make up 70% of its $18.6B portfolio in Q4 2019.
- WCM Investment Management opened 14 new positions and closed 9 in Q4 2019.
- WCM Investment Management's portfolio value rose 12% quarter-over-quarter to $18.6B.
Based on WCM Investment Management's 13F filing for Q4 2019, filed 7 Feb 2020.